NASDAQ:ITRM
Iterum Therapeutics plc
- Stock
Last Close
1.13
30/08 20:00
Market Cap
24.34M
Beta: 1.61
Volume Today
236.11K
Avg: 63.45K
PE Ratio
−0.61
PFCF: −0.64
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|
average inventory | -3.93M - | -7.95M 102.07% | -5.88M 25.95% | -3.43M 41.64% | -2.49M 27.52% | -925.50K 62.82% | |||
average payables | 2.32M - | 3.60M 55.26% | 9.76M 171.47% | 8.15M 16.52% | 847K 89.61% | 1.83M 115.58% | 3.88M 112.76% | ||
average receivables | 377K - | 615K 63.13% | 916K 48.94% | 988K 7.86% | 1.03M 4.76% | 859K 17.00% | 373K 56.58% | ||
book value per share | 44.77 - | 78.01 74.23% | 123.00 57.68% | -27.11 122.04% | -31.59 16.52% | 4.61 114.60% | 2.29 50.39% | -0.49 121.59% | |
capex per share | -1.60 - | -0.15 90.36% | -0.02 83.96% | -0.01 72.29% | -0.01 18.50% | -0.01 9.54% | -0.00 80.21% | ||
capex to depreciation | -12.49 - | -0.66 94.70% | -0.16 76.14% | -0.07 56.73% | -0.03 57.57% | -0.03 18.81% | -0.01 78.43% | ||
capex to operating cash flow | 0.03 - | 0.00 95.53% | 0.00 74.35% | 0.00 33.69% | 0.00 1,808.74% | 0.00 12.84% | 0.00 90.15% | ||
capex to revenue | -1.60 - | -0.10 93.52% | -0.65 526.31% | ||||||
cash per share | 49.00 - | 77.46 58.07% | 145.21 87.47% | 4.96 96.58% | 9.06 82.72% | 7.47 17.56% | 4.97 33.46% | 1.85 62.87% | |
days of inventory on hand | |||||||||
days payables outstanding | 1.04K - | ||||||||
days sales outstanding | 365.72 - | 302.84 17.19% | 10.96K 3,519.07% | ||||||
debt to assets | 0.14 - | 0.52 261.92% | 1.29 147.66% | 0.29 77.55% | 0.43 46.94% | 0.74 72.75% | |||
debt to equity | 0.20 - | -0.51 359.94% | -0.84 63.67% | 0.53 163.05% | 1.02 92.54% | -3.02 396.80% | |||
dividend yield | |||||||||
earnings yield | -0.14 - | -0.30 118.40% | -1.76 484.39% | -1.58 10.36% | -2.19 38.69% | -1.43 34.69% | -4.32 202.34% | -1.50 65.24% | |
enterprise value | 72.78M - | 89.10M 22.43% | 12.29M 86.21% | 68.16M 454.75% | 45.10M 33.83% | 61.49M 36.36% | 17.65M 71.29% | 38.97M 120.78% | |
enterprise value over ebitda | -5.45 - | -3.05 43.97% | -0.16 94.72% | -0.67 314.91% | -1.30 93.82% | -2.53 94.72% | -0.49 80.50% | -0.85 73.08% | |
ev to operating cash flow | -6.44 - | -2.91 54.80% | -0.16 94.44% | -0.86 433.68% | -0.83 4.28% | -3.88 369.34% | -0.96 75.38% | -0.99 3.70% | |
ev to sales | 175.40 - | 14.14 91.94% | 1.84K 12,929.05% | ||||||
free cash flow per share | -22.32 - | -62.05 178.07% | -130.49 110.29% | -81.53 37.52% | -34.07 58.21% | -1.46 95.71% | -1.51 3.74% | -3.04 100.38% | |
free cash flow yield | -0.12 - | -0.32 178.07% | -1.74 439.36% | -1.21 30.44% | -2.30 90.09% | -0.25 89.18% | -1.80 626.15% | -1.54 14.56% | |
graham net net | 40.97 - | 63.87 55.88% | 94.30 47.66% | -52.04 155.18% | -43.77 15.89% | 3.62 108.27% | 1.75 51.57% | -0.66 137.64% | |
graham number | 163.68 - | 319.29 95.07% | 605.19 89.54% | 254.94 57.87% | 151.96 40.39% | 29.54 80.56% | 13.67 53.71% | 5.74 58.05% | |
income quality | 0.84 - | 1.04 24.03% | 0.98 5.37% | 0.76 22.33% | 1.05 37.07% | 0.17 83.50% | 0.42 140.29% | 1.02 146.55% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0.04 Infinity% | 0.03 31.48% | 0 100% | |
interest coverage | 106.34 - | -179.72 269.01% | -118.49 34.07% | -2.13 98.20% | -4.42 107.65% | -12.87 191.23% | 33.24 358.31% | ||
interest debt per share | -0.55 - | 24.94 4,659.05% | 14.76 40.83% | 35.88 143.10% | 2.95 91.79% | 2.52 14.47% | 1.38 45.21% | ||
inventory turnover | |||||||||
invested capital | 0.20 - | -0.51 359.94% | -0.84 63.67% | 0.53 163.05% | 1.02 92.54% | -3.02 396.80% | |||
market cap | 97.59M - | 97.59M 0% | 43.76M 55.16% | 65.33M 49.30% | 23.75M 63.64% | 64.04M 169.60% | 10.28M 83.95% | 25.54M 148.43% | |
net current asset value | 21.61M - | 36.91M 70.78% | 58.42M 58.28% | -47.19M 180.77% | -68.84M 45.89% | 40.07M 158.20% | 22.00M 45.08% | -7.07M 132.11% | |
net debt to ebitda | 1.86 - | 0.29 84.35% | 0.41 42.09% | -0.03 106.71% | -0.61 2,113.87% | 0.10 117.05% | -0.21 296.55% | -0.29 42.86% | |
net income per share | -26.59 - | -58.08 118.40% | -132.34 127.84% | -106.55 19.48% | -32.49 69.51% | -8.41 74.12% | -3.63 56.81% | -2.96 18.48% | |
operating cash flow per share | -22.32 - | -60.45 170.88% | -130.33 115.61% | -81.50 37.47% | -34.07 58.20% | -1.45 95.73% | -1.51 3.79% | -3.03 100.98% | |
payables turnover | 0.35 - | ||||||||
receivables turnover | 1.00 - | 1.21 20.76% | 0.03 97.24% | ||||||
research and ddevelopement to revenue | 50.19 - | 79.00 57.38% | 2.45K 3,005.69% | ||||||
return on tangible assets | -0.50 - | -0.63 25.73% | -0.79 25.19% | -4.00 408.67% | -1.59 60.40% | -1.04 34.45% | -0.68 34.36% | -1.46 114.13% | |
revenue per share | 1.00 - | 1.49 48.74% | 0.04 97.44% | ||||||
roe | -0.59 - | -0.74 25.36% | -1.08 44.50% | 3.93 465.34% | 1.03 73.83% | -1.82 277.20% | -1.59 12.93% | 5.99 477.61% | |
roic | -0.59 - | -0.76 27.41% | -0.90 18.67% | 8.00 989.88% | 3.96 50.42% | -0.32 108.12% | -0.54 68.17% | -3.68 579.39% | |
sales general and administrative to revenue | 8.79 - | 10.10 14.99% | 304.97 2,918.12% | ||||||
shareholders equity per share | 44.77 - | 78.01 74.23% | 123.00 57.68% | -27.11 122.04% | -31.59 16.52% | 4.61 114.60% | 2.29 50.39% | -0.49 121.59% | |
stock based compensation to revenue | 0.77 - | 1.48 92.37% | 58.73 3,856.29% | ||||||
tangible asset value | 22.67M - | 39.49M 74.23% | 71.62M 81.35% | -26.24M 136.63% | -50.56M 92.69% | 46.80M 192.56% | 26.28M 43.84% | -6.40M 124.36% | |
tangible book value per share | 44.77 - | 78.01 74.23% | 123.00 57.68% | -27.11 122.04% | -31.59 16.52% | 4.30 113.60% | 2.15 50.02% | -0.49 123.00% | |
working capital | 21.64M - | 37.05M 71.17% | 72.45M 95.57% | -32.19M 144.42% | -14.36M 55.39% | 75.29M 624.39% | 60.64M 19.45% | 12.08M 80.08% |
All numbers in USD (except ratios and percentages)